Solventum Corporation (SOLV) Stock Price: $78.87-0.35 (-0.44%)
At close: Jun 12, 2026, 4:00 PM ET
The closing share price for Solventum Corporation (SOLV) stock was $78.87 for Friday, June 12, 2026, down 0.44% on the day.
Longer view (total return, dividends reinvested): past 12 months +6.2%
SOLV Price Chart
SOLV Key Metrics
See All MetricsSOLV Earnings Preview
Next Earnings Date
Aug 6, 2026
55 days away
EPS Estimate
1.91
Revenue Est.
$2.15B
Last Quarter Results
EPS
$1.48
vs Estimate
$1.35
Revenue
$2.01B
vs Estimate
$1.97B
SOLV Analyst Ratings
Consensus Rating
Based on 13 analysts
Average Price Target
$82.15
+4.2% upside
Low
$60.00
Current
$78.87
High
$100.00
SOLV Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | $1.55 | $1.59 | $1.63 | 3 |
| Q2 2027 | $1.84 | $1.89 | $1.94 | 2 |
| Q3 2027 | $1.72 | $1.77 | $1.81 | 2 |
| Q4 2027 | $1.86 | $1.91 | $1.96 | 2 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $6.84 | $7.06 | $7.32 | 10 |
| FY 2028 | $3.14 | $7.72 | $10.44 | 6 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | $2.04B | $2.08B | $2.13B | 3 |
| Q2 2027 | $2.16B | $2.20B | $2.25B | 3 |
| Q3 2027 | $2.00B | $2.04B | $2.08B | 3 |
| Q4 2027 | $2.09B | $2.13B | $2.18B | 3 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $8.35B | $8.47B | $8.69B | 10 |
| FY 2028 | $8.80B | $8.81B | $8.81B | 10 |
Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.
SOLV Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| 1SOLV | $13.66B | $78.87 | -0.44% | +6.17% | N/A | N/A |
SOLV Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt
About Solventum Corporation
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Bryan C. Hanson